Page last updated: 2024-08-18

cyclohexanol and Leukemia, Myeloid

cyclohexanol has been researched along with Leukemia, Myeloid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberich Jordà, M; Battista, N; Delwel, R; Löwenberg, B; Maccarrone, M; Rayman, N; Tas, M; van Lom, K; Verbakel, SE1

Other Studies

1 other study(ies) available for cyclohexanol and Leukemia, Myeloid

ArticleYear
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.
    Blood, 2004, Jul-15, Volume: 104, Issue:2

    Topics: Acute Disease; Arachidonic Acids; Bucladesine; Cannabinoid Receptor Modulators; Cell Differentiation; Cell Movement; Cyclic AMP; Cyclohexanols; Down-Regulation; Endocannabinoids; Glycerides; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ligands; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Neutrophils; Pertussis Toxin; Receptor, Cannabinoid, CB2; Receptors, Granulocyte Colony-Stimulating Factor

2004